GlaxoSmithKline PLC ADR Capital Reinvestment Ratio
GlaxoSmithKline PLC ADR capital reinvestment ratio. GlaxoSmithKline PLC ADR (GSK) has a Capital Reinvestment Ratio of 0.13x as of June 2026, meaning it reinvests 0% of its operating cash flow ($2.54 Billion) in capital expenditures ($328.95 Million). Check how aggressively does GlaxoSmithKline PLC ADR reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of GlaxoSmithKline PLC ADR (1990–2025)
Capital reinvestment ratio of GlaxoSmithKline PLC ADR from 1990 to 2025. This chart tracks GlaxoSmithKline PLC ADR's Capital Reinvestment Ratio across 36 annual periods. Also explore GlaxoSmithKline PLC ADR (GSK) equity growth momentum to track the company's year-over-year net asset growth rate.
GlaxoSmithKline PLC ADR Capital Reinvestment Ratio by Year (1990–2025)
GlaxoSmithKline PLC ADR capital reinvestment ratio by year from 1990 to 2025. For the full cash flow conversion analysis, see GSK operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | $7.14 Billion | $1.32 Billion | ▼ -59.4% |
| 2024 | 0.45x | $6.55 Billion | $2.98 Billion | ▲ +119.8% |
| 2023 | 0.21x | $7.89 Billion | $1.63 Billion | ▼ -32.1% |
| 2022 | 0.31x | $7.40 Billion | $2.26 Billion | ▼ -17.2% |
| 2021 | 0.37x | $7.95 Billion | $2.93 Billion | ▲ +39.0% |
| 2020 | 0.27x | $8.44 Billion | $2.24 Billion | ▼ -1.6% |
| 2019 | 0.27x | $8.02 Billion | $2.16 Billion | ▲ +26.5% |
| 2018 | 0.21x | $8.42 Billion | $1.80 Billion | ▼ -33.0% |
| 2017 | 0.32x | $6.92 Billion | $2.20 Billion | ▼ -12.1% |
| 2016 | 0.36x | $6.50 Billion | $2.35 Billion | ▼ -51.1% |
| 2015 | 0.74x | $2.57 Billion | $1.90 Billion | ▲ +118.7% |
| 2014 | 0.34x | $5.18 Billion | $1.75 Billion | ▲ +43.6% |
| 2013 | 0.24x | $7.22 Billion | $1.70 Billion | ▼ -32.2% |
| 2012 | 0.35x | $4.38 Billion | $1.52 Billion | ▲ +63.5% |
| 2011 | 0.21x | $6.25 Billion | $1.33 Billion | ▼ -11.7% |
| 2010 | 0.24x | $6.80 Billion | $1.64 Billion | ▲ +0.7% |
| 2009 | 0.24x | $7.84 Billion | $1.87 Billion | ▼ -15.6% |
| 2008 | 0.28x | $7.31 Billion | $2.07 Billion | ▼ -18.6% |
| 2007 | 0.35x | $6.17 Billion | $2.14 Billion | ▼ -10.9% |
| 2006 | 0.39x | $4.08 Billion | $1.59 Billion | ▲ +104.6% |
| 2005 | 0.19x | $6.20 Billion | $1.18 Billion | ▲ +269.3% |
| 2004 | 0.05x | $4.94 Billion | $255.00 Million | ▼ -76.4% |
| 2003 | 0.22x | $4.85 Billion | $1.06 Billion | ▼ -45.4% |
| 2002 | 0.40x | $3.06 Billion | $1.23 Billion | ▲ +65.4% |
| 2001 | 0.24x | $4.61 Billion | $1.12 Billion | ▼ -59.3% |
| 2000 | 0.60x | $1.85 Billion | $1.10 Billion | ▼ -49.1% |
| 1999 | 1.17x | $510.00 Million | $597.00 Million | ▲ +1.0% |
| 1998 | 1.16x | $410.00 Million | $475.00 Million | ▲ +71.7% |
| 1997 | 0.67x | $615.00 Million | $415.00 Million | ▲ +42.9% |
| 1996 | 0.47x | $849.00 Million | $401.00 Million | ▼ -13.5% |
| 1995 | 0.55x | $1.25 Billion | $684.00 Million | ▲ +175.5% |
| 1994 | 0.20x | $2.45 Billion | $485.59 Million | ▼ -63.7% |
| 1993 | 0.55x | $1.05 Billion | $575.00 Million | ▼ -16.7% |
| 1992 | 0.66x | $927.00 Million | $608.00 Million | ▼ -27.5% |
| 1991 | 0.90x | $657.00 Million | $594.00 Million | ▼ -8.2% |
| 1990 | 0.99x | $615.00 Million | $606.00 Million | — |